Good Morning, Traders!…👋

U.S. stock futures hovered near the flatline Friday, signaling a muted close to a week that opened with optimism over easing global trade tensions.

Wall Street ended Thursday’s session mixed, as traders weighed the impact of a U.S.-China trade truce that, while encouraging, may not fully dispel lingering growth concerns tied to aggressive tariff policies.

Walmart (NYSE: WMT) added to cautionary signals, warning it may soon raise prices due to higher U.S. levies—a move that analysts say could be echoed across the retail sector.

Meanwhile, fresh economic data pointed to a slowdown in producer prices and continued weakness in core retail sales, adding to the market’s cautious tone.

Earnings Watch

Earnings hit today from Walmart $WMT, Alibaba $BABA, and Deere $DE before open, plus Applied Materials $AMAT, CAVA $CAVA, and Take-Two $TTWO after close.

Analysts expect Walmart to post $0.57 EPS with retail strength, Alibaba to hit $1.27 EPS on e-commerce growth, Deere at $5.68 EPS, AMAT to deliver $2.29 EPS with chip demand, CAVA at $0.05 EPS, and TTWO at $0.06 EPS—could these beats spark rallies?

Happening Today

✓ 08:30 AM ET – Building Permits (Apr)

✓ 08:30 AM ET – Housing Starts (Apr)

✓ 08:30 AM ET – Import & Export Price Index (MoM) (Apr)

✓ 10:00 AM ET – Michigan Consumer Expectations (May)

✓ 03:30 PM ET – CFTC Nasdaq 100 and S&P 500 speculative net positions

✓ 04:00 PM ET – TIC Net Long-Term Transactions (Mar)

✓ 09:40 PM ET – FOMC Member Daly Speaks

PREMARKET SNAPSHOT 📈

U.S. equity futures edged higher this morning, buoyed by optimism over easing U.S.-China trade tensions and expectations of potential Federal Reserve rate cuts later this year.

SECTOR SNAPSHOT✨

Markets saw a mixed session, with tech and communication services leading the gains while most other sectors slipped. Information technology rose nearly 1%, and communication services added over 1.5%, offsetting weakness in healthcare, which declined more than 2%. Real estate, energy, and materials also posted notable losses, while consumer discretionary eked out modest gains.  

PreMarket Unusual Volume Stocks

📈 Cabaletta Bio, Inc. $CABA is gaining attention with a 9.39% pre-market rise and volume of 2.07M shares, up over 1,440% from average. The biotech stock is drawing strong interest—potentially ahead of clinical updates or investor events.

📈 Biofrontera Inc. $BFRI is up nearly 10% in early action with volume at 181.9K, a 681% spike. This surge may reflect renewed interest in its dermatology pipeline or upcoming catalysts.

📈 Treasure Global Inc. $TGL has soared 29.67% pre-market with 6.51M shares traded—460% above normal levels. The sharp uptick signals heightened speculative activity around the stock, possibly linked to earnings or corporate developments.

📈 Gryphon Digital Mining, Inc. $GRYP is climbing 8.41% with volume hitting 1.33M, a 343% increase. The move could be tied to momentum in crypto markets or investor interest in mining efficiency updates.

📈 TSS, Inc. $TSSI is up 43.18%, trading 651.3K shares—more than 338% above its average. The volume spike hints at strong market reaction, potentially tied to contract wins or M&A chatter.

Premarket Picks

Incannex Healthcare Inc. (IXHL) saw its shares surge 34.18% in pre-market trading, reaching $0.36. The spike follows the release of the company’s fiscal third-quarter 2025 financial results, which attracted strong investor interest.

TSS, Inc. (TSSI) jumped 44.64% to $12.83 in pre-market activity after an impressive first-quarter 2025 report. The company posted revenue of $99 million—a massive 523% increase—along with earnings per share of $0.12.

Treasure Global Inc. (TGL) climbed 39.56% in pre-market hours, trading at $2.54. The company’s third-quarter 2025 results highlighted a 41% year-over-year jump in gross profit to $0.49 million, with gross margins soaring to 73% from just 14% a year ago.

Legacy Education Inc. (LGCY) rose 22.11% to $9.50 pre-market. The company delivered a record third quarter, boasting 50% revenue growth and crossing the milestone of over 3,000 enrolled students.

Below is a complete list of hot stocks in pre-market today:

Top Upgrades:

1. Pentair plc (PNR)

Analyst Firm: JPMorgan
Upgraded: Neutral to Overweight
Price Target: $113
Yesterday's Close: $97.81

JPMorgan raised its rating on Pentair from Neutral to Overweight and increased its price target from $90 to $113.

Analysts have set a stock price target for Pentair plc ranging from a low of $84.00 to a high of $115.00, with a median estimate of $102.50 and an average of $102.89. The company delivers water solutions across multiple global markets, including the U.S., Europe, China, Latin America, and more.

2. Huntington Ingalls Industries, Inc. (HII)

Analyst Firm: Alembic Global
Upgraded: Neutral to Overweight
Price Target: $265
Yesterday's Close: $228.16

Alembic Global also upgraded HII from Neutral to Overweight, setting a new price target of $265.

Huntington Ingalls Industries has received price targets from analysts ranging between $166.00 and $286.00. The median forecast stands at $235.00, while the average target is $225.73. The company specializes in designing, building, overhauling, and repairing military ships in the United States.

3. Fulcrum Therapeutics, Inc. (FULC)

Analyst Firm: Cantor Fitzgerald
Upgraded: Neutral to Overweight
Price Target: $10
Yesterday's Close: $6.60

Cantor Fitzgerald upgraded Fulcrum Therapeutics to Overweight from Neutral, assigning a price target of $10.

For Fulcrum Therapeutics, stock price targets range from $2.00 to $12.00, with a median of $4.00 and an average of $6.00. This U.S.-based biopharmaceutical firm focuses on developing small molecule therapies to address serious genetic diseases with unmet medical needs.

Happy investing,

Maeve Grace
Editor In Chief
Premium Stock Alerts

Important: This newsletter does not provide investment advice. The stocks mentioned should not be taken as recommendations. Your investments are solely your decisions.

Disclosure: I hold no positions in any companies mentioned, either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article.